These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2901344)

  • 21. Structure-function relationships of the human T lymphocyte CD2 antigen.
    Brown MH; Monostori E; Gullberg M; Zamoyska R; Lang G; Kioussis D; Crumpton MJ
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():627-36. PubMed ID: 2577024
    [No Abstract]   [Full Text] [Related]  

  • 22. CD2 and CD3 antigens mobilize Ca2+ independently.
    O'Flynn K; Knott LJ; Russul-Saib M; Abdul-Gaffar R; Morgan G; Beverley PC; Linch DC
    Eur J Immunol; 1986 May; 16(5):580-4. PubMed ID: 3084290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sheep erythrocyte rosetting induces multiple alterations in T lymphocyte function: inhibition of T cell receptor activity and stimulation of T11/CD2.
    Breitmeyer JB; Faustman DL
    Cell Immunol; 1989 Oct; 123(1):118-33. PubMed ID: 2570643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential responsiveness to CD3-Ti vs. CD2-dependent activation of human intestinal T lymphocytes.
    Pirzer UC; Schürmann G; Post S; Betzler M; Meuer SC
    Eur J Immunol; 1990 Oct; 20(10):2339-42. PubMed ID: 1978710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane.
    Bagnasco M; Nunes J; Lopez M; Cerdan C; Pierres A; Mawas C; Olive D
    Eur J Immunol; 1989 May; 19(5):823-7. PubMed ID: 2567674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vivo functional immune system lacking polyclonal T-cell surface expression of the CD3/Ti(WT31) complex.
    Regueiro JR; López-Botet M; De Landazuri MO; Alcami J; Corell A; Martín-Villa JM; Vicario JL; Arnaiz-Villena A
    Scand J Immunol; 1987 Dec; 26(6):699-708. PubMed ID: 2962274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD45R+ cells are preferentially activated through the CD2 pathway.
    Matsuyama T; Anderson P; Daley JF; Schlossman S; Morimoto C
    Eur J Immunol; 1988 Sep; 18(9):1473-6. PubMed ID: 2458944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
    Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
    J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of human T cells by neuraminidase-galactose oxidase-treated erythrocytes involving CD2 (T11) and its complementary structure.
    Ocklind G; Talts J; Lindahl-Kiessling K
    Scand J Immunol; 1988 Jun; 27(6):697-704. PubMed ID: 2899354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD3Ti+ human thymocyte-derived clones displaying a differential response to activation via CD3Ti and CD2.
    Testi R; Alcover A; Spagnoli G; Reinherz EL; Acuto O
    Cell Immunol; 1989 Sep; 122(2):350-64. PubMed ID: 2569934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstitution of an active surface CD2 by DNA transfer in CD2-CD3+ Jurkat cells facilitates CD3-T cell receptor-mediated IL-2 production.
    Makni H; Malter JS; Reed JC; Nobuhiko S; Lang G; Kioussis D; Trinchieri G; Kamoun M
    J Immunol; 1991 Apr; 146(8):2522-9. PubMed ID: 1707910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.
    Cerdan C; Lipcey C; Lopez M; Nunes J; Pierres A; Mawas C; Olive D
    Cell Immunol; 1989 Oct; 123(2):344-53. PubMed ID: 2571421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.
    Nel AE; Ledbetter JA; Williams K; Ho P; Akerley B; Franklin K; Katz R
    Immunology; 1991 Jun; 73(2):129-33. PubMed ID: 1676984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.
    Faure F; Jitsukawa S; Meuer S; Bohuon C; Triebel F; Hercend T
    J Immunol; 1988 Apr; 140(7):2128-32. PubMed ID: 2895149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells.
    Breitmeyer JB; Daley JF; Levine HB; Schlossman SF
    J Immunol; 1987 Nov; 139(9):2899-905. PubMed ID: 2444644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens.
    Friedrich B; Cantrell DA; Gullberg M
    Eur J Immunol; 1989 Jan; 19(1):17-23. PubMed ID: 2563972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells.
    Alés-Martínez JE; Alvarez-Mon M; Merino F; Bonilla F; Martínez C; Durántez A; De la Hera A
    Eur J Immunol; 1988 Nov; 18(11):1827-30. PubMed ID: 2462502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.